Clinical Value of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography/Computed Tomography in Bladder Cancer

PURPOSE: Fluorine-18 2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomography (PET)/computed tomography (CT) has been approved for imaging in many malignancies but not for bladder cancer. This study investigated the value of FDG-PET/CT imaging in the management of patients with advanced bladder...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Apolo, Andrea B., Riches, Jamie, Schöder, Heiko, Akin, Oguz, Trout, Alisa, Milowsky, Matthew I., Bajorin, Dean F.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2940395/
https://ncbi.nlm.nih.gov/pubmed/20679618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.28.7052
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items